| CYHS2000247 | 恩格列净片 | empagliflozin | Tablet | Chemical Drugs(4) | Generic Drug | 2020-04-20 | 江苏奥赛康药业有限公司 | Jiangsu Aosaikang Pharmaceutical Co Ltd | Certificate Issued | 2021-11-19 | view |
| CYHS1900393 | 恩格列净片 | empagliflozin | Tablet | Chemical Drugs(4) | Generic Drug | 2019-06-10 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | Certificate Issued | 2021-02-05 | view |
| CYHS1800511 | 恩格列净片 | empagliflozin | Tablet | Chemical Drugs(4) | Generic Drug | 2018-12-29 | 正大天晴药业集团股份有限公司 | Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd | Certificate Issued | 2021-02-03 | view |
| CYHS1800510 | 恩格列净片 | empagliflozin | Tablet | Chemical Drugs(4) | Generic Drug | 2018-12-29 | 正大天晴药业集团股份有限公司 | Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd | Certificate Issued | 2021-02-03 | view |
| JYHB2002594 | 二甲双胍恩格列净片（Ⅵ） | empagliflozin;metformin hydrochloride | Tablet | Chemical Drugs | Supplementary Application | 2020-12-18 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | Certificate Issued | 2021-01-08 | view |
| JYHB2002593 | 二甲双胍恩格列净片（Ⅴ） | empagliflozin;metformin hydrochloride | Tablet | Chemical Drugs | Supplementary Application | 2020-12-18 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | Certificate Issued | 2021-01-08 | view |
| CYHS2000970 | 恩格列净片 | empagliflozin | Tablet | Chemical Drugs(4) | Generic Drug | 2021-01-05 | 扬子江药业集团北京海燕药业有限公司 | Yangtze River Pharmaceutical Group Beijing Haiyan Pharmaceutical Co Ltd | In Review | 2021-01-04 | view |
| CYHS2000969 | 恩格列净片 | empagliflozin | Tablet | Chemical Drugs(4) | Generic Drug | 2021-01-05 | 扬子江药业集团北京海燕药业有限公司 | Yangtze River Pharmaceutical Group Beijing Haiyan Pharmaceutical Co Ltd | In Review | 2021-01-04 | view |
| JXHL2000320 | 恩格列净片 | empagliflozin | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2020-12-14 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | In Review | 2020-12-10 | view |
| JXHS2000168 | 恩格列净片 | empagliflozin | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2020-11-18 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | In Review | 2020-11-18 | view |
| JYHF2000084 | 恩格列净片 | empagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2020-09-03 | 上海勃林格殷格翰药业有限公司 | Boehringer Ingelheim Shanghai Pharmaceuticals Co Ltd | Filed | 2020-09-11 | view |
| JYHB2001001 | 二甲双胍恩格列净片（Ⅳ） | empagliflozin;metformin hydrochloride | Tablet | Chemical Drugs | Supplementary Application | 2020-07-03 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | Certificate Issued | 2020-08-21 | view |
| JYHB2001000 | 二甲双胍恩格列净片（Ⅲ） | empagliflozin;metformin hydrochloride | Tablet | Chemical Drugs | Supplementary Application | 2020-07-03 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | Certificate Issued | 2020-08-21 | view |
| CYHS1800426 | 恩格列净片 | empagliflozin | Tablet | Chemical Drugs(4) | Generic Drug | 2018-11-21 | 四川科伦药业股份有限公司 | Sichuan Kelun Pharmaceutical Co Ltd | Certificate Issued | 2020-08-19 | view |
| CYHS1800425 | 恩格列净片 | empagliflozin | Tablet | Chemical Drugs(4) | Generic Drug | 2018-11-21 | 四川科伦药业股份有限公司 | Sichuan Kelun Pharmaceutical Co Ltd | Certificate Issued | 2020-08-19 | view |
| CYHS1800412 | 恩格列净片 | empagliflozin | Tablet | Chemical Drugs(4) | Generic Drug | 2018-11-14 | 江苏豪森药业集团有限公司 | Jiangsu Hansoh Pharmaceutical Group Co Ltd | Certificate Issued | 2020-08-03 | view |
| CYHS1800411 | 恩格列净片 | empagliflozin | Tablet | Chemical Drugs(4) | Generic Drug | 2018-11-14 | 江苏豪森药业集团有限公司 | Jiangsu Hansoh Pharmaceutical Group Co Ltd | Certificate Issued | 2020-08-03 | view |
| JYHB1901546 | 恩格列净片 | empagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2019-12-28 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | Certificate Issued | 2020-07-28 | view |
| JYHB1901549 | 恩格列净片 | empagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2019-12-14 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | Certificate Issued | 2020-07-28 | view |
| JYHB1901547 | 恩格列净片 | empagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2019-12-14 | 勃林格殷格翰（中国）投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | Certificate Issued | 2020-07-28 | view |
